Satellos Bioscience Inc. (MSCL) — Financial Flexibility Index
Satellos Bioscience Inc. (MSCL) has a Financial Flexibility Index of -1.80x as of December 2025. Free cash flow of CA$-7.38 Million (operating CF CA$-7.38 Million minus capex CA$5.83) represents -2% of total liabilities (CA$4.10 Million). Also explore Satellos Bioscience Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Satellos Bioscience Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Satellos Bioscience Inc. across 7 annual periods. Check MSCL PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Satellos Bioscience Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for Satellos Bioscience Inc.. For the full company profile including market capitalisation, see MSCL stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.86x | CA$-24.00 Million | CA$-24.01 Million | CA$4.10 Million | ▼ -20.9% |
| 2024 | -4.84x | CA$-24.97 Million | CA$-24.98 Million | CA$5.16 Million | ▼ -21.9% |
| 2023 | -3.97x | CA$-14.40 Million | CA$-14.42 Million | CA$3.62 Million | ▼ -94.5% |
| 2022 | -2.04x | CA$-5.78 Million | CA$-5.78 Million | CA$2.83 Million | ▲ +14.5% |
| 2021 | -2.39x | CA$-5.03 Million | CA$-5.03 Million | CA$2.10 Million | ▼ -89.0% |
| 2020 | -1.26x | CA$-1.66 Million | CA$-1.66 Million | CA$1.31 Million | ▲ +56.3% |
| 2019 | -2.89x | CA$-1.92 Million | CA$-1.92 Million | CA$664.81K | — |